Sunday, September 21, 2014

We can extract secrets from genes, but should we?

From page A10 | July 14, 2013 |

Here’s something that hasn’t gotten as much publicity as I would expect: There is a gene associated with Alzheimer’s disease.
I learned this quite by accident, after I impulsively signed up to have my genes decoded. It’s not as simple as “you have the gene, you get Alzheimer’s,” but the gene may be a marker for the disease or involved in its development.
I’ll start at the beginning of this story when, a couple of months ago, I fell prey to that attractive word “free.” Someone in Davis had landed 100 free genetic screenings from 23andMe, an upcoming company that analyzes part of your DNA (normally for $99) and performs genetic research. The catch was that I had to sign up quickly.
I raced through the written warnings and details, pausing only to consider whether I might have trouble buying insurance if I turned out to carry the gene for an expensive disease. I decided that at my age (66), with Medicare already in place, I had little to lose.
I was thrilled that the company promised details about ancestry. Although I’m not the type to meticulously reconstruct a family tree, I am curious about where my relatives came from before they lived in Berlin (my father’s family) and Sicily (my mother’s). I knew that 23andMe also would furnish health information, but I didn’t spend time imagining what that might be.
Three weeks later a perfectly packaged little tube arrived, ready for me to spit into it, put it into the prepaid box and send it to 23andMe. Again, I read little. I spit and sent.
Three weeks later, while I was visiting my grandkids in Chicago, I got a message saying that my health data was available, although ancestry would take a couple more weeks. I rushed to the web page that offered my results.
This page contains five columns. On the left are the names of gene-related diseases. Next comes a column with stars to indicate how certain 23andMe is of its result. Four stars means very certain. The other columns are devoted to comparing “typical” results to the ones from my DNA.
For example, I am slightly more likely than most people to get colon cancer, but less likely to fall prey to melanoma or Crohn’s disease.
The results that pulled me up short, however, were for the first disease on the list: Alzheimer’s. Instead of “my numbers” I found four stars (indicating certainty about the results) and a picture of a padlock.
It turns out that for this dreadful, incurable disease (and several others, like Parkinson’s), the company wants you to read their information carefully before you click on the padlock and take a look.
So I read. This is when I first learned that there are genetic markers for Alzheimer’s. No one-to-one correlation exists between having the APOE4 gene and getting the disease, but the gene implies increased risk, double that of other people — or more.
At the same time, results regarding Alzheimer’s may not be reliable because researchers don’t yet understand what causes the disease. Genes may be a side issue, not the causative factor.
Finally willing to slow down, I watched 23andMe’s videotape about Alzheimer’s disease. Then I returned to the home page and stared at the lockbox that concealed my results.
While doing so, I thought about my recent reaction to negative results on a different kind of medical test. For six months — even when I didn’t consciously think about the test — I felt distressed and sad until, finally, a second test allowed me to relax.
I’ve told myself that if I plan to get older, I need to learn how to deal with health worries in a more balanced manner, but I’m not there yet, not at all.
I sat down with my husband, my daughter and my son-in-law and told them about 23andMe. We discussed how knowing about a potential medical problem gives you time to take preventive measures. Although nothing works yet to delay or slow the progression of Alzheimer’s, new drugs are being studied all the time.
I thought, “Maybe it would be good to know my results.”
My husband, the person who knows me best, hesitated. He reminded me how tense I had been about my other health issue. We also thought about the fact that my results might give our children information about their risk, and their children’s risk, that they might not want.
I kept the lockbox closed, and instead contacted the company to ask how long they would keep my results. They told me they don’t plan to erase anything, except at the request of the customer.
This gives me time to think the whole thing over, to learn to manage my tendency to worry about health, as I’ve already committed to do, and to look into the issue of genetic testing and how to handle your personal results.
For now, count me as a person who has not opened her lockbox. If others in Davis have made a different choice, I’d love to hear about it. In the meantime, I’m reading ferociously about personal genetics — likely a big topic in the next few years — and you may see more columns from me about this soon.
— Marion Franck lives in Davis with her family. Reach her at





Elementary school counselors: necessary, but poorly funded

By Anne Ternus-Bellamy | From Page: A1 | Gallery

Bet Haverim hosts High Holy Day services

By Special to The Enterprise | From Page: A1

Teams assess damage as wildfire burns

By The Associated Press | From Page: A2 | Gallery

Driver arrested for DUI after Saturday morning crash

By Enterprise staff | From Page: A2

Help raise funds for juvenile diabetes cure

By Enterprise staff | From Page: A3

Jewelry, art for sale at Senior Center

By Enterprise staff | From Page: A3

Davis Community Meals needs cooks

By Enterprise staff | From Page: A3

Hawk Hill trip planned Sept. 30

By Enterprise staff | From Page: A4

UC campus chancellors granted hefty pay raises

By The Associated Press | From Page: A4

Send kids to camp!

By Enterprise staff | From Page: A4

Da Vinci awarded $38,000 for restorative justice program

By Anne Ternus-Bellamy | From Page: A4

Outdoor yoga marathon celebrates community

By Special to The Enterprise | From Page: A5

Wise words

By Sue Cockrell | From Page: A12



Awareness is key to this fight

By Creators Syndicate | From Page: B5

Where is this going?

By Creators Syndicate | From Page: A6

We’re living in the Golden State of emergency

By Debra DeAngelo | From Page: A6

Options for protection come with flu season

By The Associated Press | From Page: A6

Are we there yet? Not enough hours in the day to goof off

By Tanya Perez | From Page: A6Comments are off for this post

Don’t sell city greenbelt

By Letters to the Editor | From Page: A10

Paso Fino project is flawed

By Letters to the Editor | From Page: A10

Paso Fino — it’s not worth it

By Letters to the Editor | From Page: A10

Archer will get my vote

By Letters to the Editor | From Page: A10

It’s time for Davis Scouts to stand up for what is right

By Special to The Enterprise | From Page: A10

Mike Keefe cartoon

By Debbie Davis | From Page: A10

Building something at schools’ HQ

By Our View | From Page: A10

Speak out

By Enterprise staff | From Page: A11

Maybe David can beat Goliath again

By Lynne Nittler | From Page: A11 | Gallery



DHS gets on its Morse to beat Edison

By Thomas Oide | From Page: B1 | Gallery

JV Blue Devils drop low-scoring affair

By Spencer Ault | From Page: B2

Republic FC’s fairy tale season continues

By Evan Ream | From Page: B3 | Gallery

Wire briefs: Giants rally falls short in San Diego

By The Associated Press | From Page: B3

Four local swimmers qualify for Olympic Trials

By Enterprise staff | From Page: B3

‘We’re a way better team’ than record, says UCD’s Shaffer

By Bruce Gallaudet | From Page: B4 | Gallery

UCD roundup: Aggie men pound Pomona-Pitzer in the pool

By Enterprise staff | From Page: B4

Davis 15-year-old making a splash in European F4 series

By Bruce Gallaudet | From Page: B8 | Gallery





‘Ladies Foursome’ adds shows

By Enterprise staff | From Page: A3



UCD grad’s startup earns kudos at TechCrunch event

By Special to The Enterprise | From Page: A7

Styles on target for November debut

By Wendy Weitzel | From Page: A7

MBI hires VP of marketing

By Enterprise staff | From Page: A7

Taylor Morrison unveils new Woodland community next weekend

By Special to The Enterprise | From Page: A9 | Gallery

Rob White: What is an ‘innovation center’?

By Rob White | From Page: A9



Carol L. Walsh

By Special to The Enterprise | From Page: A4



Comics: Sunday, September 21, 2014

By Creator | From Page: B8